FIELD: medicine.
SUBSTANCE: invention relates to medicine and offers a new pharmaceutical composition for treatment of depression; the composition includes therapeutically efficient quantity of compound of the formula (I) 
or its pharmaceutically acceptable salt; and therapeutically efficient quantity of the selective serotonin reuptake inhibitor; the application of the compound of the formula (I) is offered for production of the medications to cure depressions.
EFFECT: invention provides the composition suitable for treatment of depressions without undesirable side effects associated with nonselective interaction of the receptors.
16 cl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF N-DISMETILKLOSAPINE FOR HUMAN NEUROPSYCHIATRIC DISEASES TREATMENT | 2004 |
|
RU2336879C2 |
| METHOD OF TREATING NEUROLOGICAL DISORDERS | 2008 |
|
RU2492137C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF FUNCTIONAL MENTAL DISORDERS | 2016 |
|
RU2667954C2 |
| ORGANIC COMPOUNDS | 2017 |
|
RU2733975C2 |
| LIGAND WITH WIDE RANGE OF SIMULTANEOUS RECEPTOR ACTIVITY, PHARMACEUTICAL COMPOSITION, METHOD OF PREPARING SAID COMPOSITION AND MEDICINAL AGENT | 2008 |
|
RU2374245C1 |
| SPIROAZACYCLIC COMPOUNDS, METHOD FOR INHIBITION IF ACTIVITY OR ACTIVATION OF SEROTONIN 5-НТ2А RECEPTOR, METHOD FOR TREATMENT OF MORBID STATE ASSOCIATED WITH SEROTONIN 5-НТ2А RECEPTOR AND THEIR USING | 2002 |
|
RU2315051C2 |
| ORGANIC COMPOUNDS | 2015 |
|
RU2785871C2 |
| ORGANIC COMPOUNDS | 2015 |
|
RU2728787C2 |
| ORGANIC COMPOUNDS | 2018 |
|
RU2777366C2 |
| SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS, USED AS THERAPEUTICS FOR NEURODEGENERATIVES DISEASES | 2004 |
|
RU2332401C2 |
